Option Care Health (OPCH) Stock
Home infusion services provider for patients outside hospitals. Here's the price, business snapshot, and what's worth knowing about Option Care Health in August 2026.
Option Care Health (OPCH) is a US-based provider of home and alternate-site infusion services, supplying complex infusion therapies and related services to patients outside traditional hospital settings. The company partners with payers, providers and pharmaceutical manufacturers to deliver treatments for chronic and acute conditions, aiming to lower costs by shifting care to lower-cost settings. Key drivers for investors to watch include the secular shift towards outpatient care, an ageing population that increases demand for infusion therapies, and contract wins with payers and drug makers. Risks include reimbursement pressure, regulatory scrutiny, operational complexity and labour shortages, which can affect margins and volumes. With a market capitalisation of about $4.58bn, Option Care’s prospects depend on successful integration of acquired businesses, margin management and negotiating favourable terms with payers. This information is educational and not personalised advice; investors should review the latest filings, financial statements and seek professional guidance before acting.
Stock Performance Snapshot
Analyst Rating
Analysts recommend buying Option Care Health Inc. stock, with a target price of $36.64.
Financial Health
Option Care Health Inc is performing well with solid revenue and cash flow generation.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Discover More Opportunities
CHEMED CORP
Provides hospice and palliative care services to patients facing life-limiting illness
Brookdale
A leading owner and operator of senior living communities in the United States.
ACADIA HEALTHCARE
Provides behavioral health care services in the United States.
Baskets Featuring OPCH
Medicare Advantage Rate Hike Opportunities in 2026
The Centers for Medicare & Medicaid Services finalized a 2.48% payment increase for 2027, granting health insurers a surprise $13 billion funding boost. This collection features managed care organizations and healthcare providers poised to benefit from this highly favorable regulatory reversal.
Published: 10 April 2026
Explore BasketJob Growth Surge: Which Industries Could Capitalise?
ADP reported that the private sector added 62,000 jobs in March, beating expectations and highlighting strong wage gains for job-changers. This steady labor market resilience presents a compelling investment case for healthcare providers, educational services, and human capital management firms.
Published: 2 April 2026
Explore BasketMedicare Cost Stocks (UNH, CVS) May Benefit
The U.S. government's successful negotiation of lower prices for key Medicare drugs signals a major shift in pharmaceutical pricing power. This creates a potential investment opportunity in managed care and healthcare service companies poised to benefit from the system's increased focus on cost efficiency.
Published: 26 November 2025
Explore BasketWalgreens Restructuring Explained: Investment Shifts
Following its acquisition by Sycamore Partners, Walgreens has gone private and split into five companies. This theme explores the investment opportunities created by the newly independent healthcare and retail entities.
Published: 2 September 2025
Explore BasketAt-Home Treatment Revolution | FDA Approval Impact
The FDA's approval of an injectable, at-home version of Eisai and Biogen's Alzheimer's drug signals a major shift in chronic disease management. This creates an investment opportunity in companies that develop advanced drug delivery systems and support at-home patient care.
Published: 1 September 2025
Explore BasketAt-Home Healthcare Stocks Explained | FDA Approval
The FDA's approval of an injectable, at-home version of Eisai and Biogen's Alzheimer's drug simplifies treatment and reduces the need for hospital visits. This development highlights a broader trend toward at-home care, creating potential investment opportunities in companies that provide related medical devices and healthcare services.
Published: 30 August 2025
Explore BasketWalgreens' Restructuring: A New Healthcare Landscape
Following its $10 billion acquisition by Sycamore Partners, Walgreens is going private and splitting into five separate companies. This major restructuring of a key industry player could create significant opportunities for competitors and specialized healthcare service providers to capture market share.
Published: 29 August 2025
Explore BasketNavigating U.S. Drug Price Reforms
The White House is demanding major pharmaceutical companies slash U.S. drug prices, creating significant market volatility and threatening industry profits. This creates a potential opening for companies that offer cost-saving alternatives, such as generic drug makers and healthcare service providers.
Published: 5 August 2025
Explore BasketRiding The Regulatory Wave In Healthcare
The Department of Justice's investigation into UnitedHealth's Medicare billing practices has cast a shadow over the health insurance industry, potentially leading to stricter oversight. This creates an investment opportunity in companies that provide compliance and auditing services, which are essential for navigating a more complex regulatory environment.
Published: 25 July 2025
Explore BasketWhy You’ll Want to Watch This Stock
Outpatient care shift
The move from hospitals to home care can lower costs and expand volume, though reimbursement and execution risks may affect outcomes.
Demographic tailwinds
An ageing population increases demand for chronic therapies delivered at home, yet demand can vary with policy and payer decisions.
Operational complexity
Success depends on supply-chain, clinical operations and payer contracts; operational missteps or labour shortages could dent margins.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
